近5年高被引文献
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
article
Full Text
OpenAlex
1183
FWCI241.39
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
review
Full Text
OpenAlex
523
FWCI25.462
FDA approves 100th monoclonal antibody product
review
Full Text
OpenAlex
444
FWCI14.426
The past, present, and future of antibiotics
review
Full Text
OpenAlex
419
FWCI15.619
Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future
review
Full Text
OpenAlex
281
FWCI5.425
Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
review
Full Text
OpenAlex
270
FWCI10.058
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning
article
Full Text
OpenAlex
248
FWCI30.613
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment
review
Full Text
OpenAlex
246
FWCI12.719
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
review
Full Text
OpenAlex
241
FWCI13.976